Amyris (Amyris) 12-1 Month Momentum % : -99.48% (As of Apr. 27, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Amyris 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-27), Amyris's 12-1 Month Momentum % is -99.48%.

The industry rank for Amyris's 12-1 Month Momentum % or its related term are showing as below:

AMRSQ's 12-1 Month Momentum % is not ranked
in the Chemicals industry.
Industry Median: -5.93 vs AMRSQ: -99.48

Competitive Comparison of Amyris's 12-1 Month Momentum %

For the Specialty Chemicals subindustry, Amyris's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amyris's 12-1 Month Momentum % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Amyris's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Amyris's 12-1 Month Momentum % falls into.

Amyris (OTCPK:AMRSQ) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amyris (OTCPK:AMRSQ) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Amyris 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Amyris's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Amyris (Amyris) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Amyris Inc (OTCPK:AMRSQ) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5885 Hollis Street, Suite 100, Emeryville, CA, USA, 94608

Website

https://www.amyris.com

Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.

Executives

J. Scott White	director	100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Philip J. Gund	officer: Chief Restructuring Officer	C/O SUNEDISON, INC., 13736 RIVERPORT DR., MARYLAND HEIGHTS MO 63043
M. Freddie Reiss	director	2951 28TH STREET, SUITE 1000, SANTA MONICA CA 90405
Hermanus Kieftenbeld	officer: Chief Financial Officer	259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Eduardo Alvarez	officer: Chief Operating Officer	AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608
Elizabeth E. Dreyer	officer: CHIEF ACCOUNTING OFFICER	EDGEWELL PERSONAL CARE, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017
Frank Kung	director	C/O VIVO CAPITAL, 505, PALO ALTO CA 94301
Nicole Kelsey	officer: General Counsel and Secretary	AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608
John Melo	director, officer: President and CEO	C/O AMYRIS, INC., 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608
Anthony Hughes	officer: Chief Accounting Officer	5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608
Ana Dutra	director	C/O KORN/FERRY INTERNATIONAL, 1900 AVENUE OF THE STARS, SUITE 2600, LOS ANGELES CA 90067
James F Mccann	director	ONE OLD COUNTRY ROAD, SUITE 500, CARLE PLACE NY 11514
Ryan Panchadsaram	director	5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608
L John Doerr	director, 10 percent owner	C/O KLEINER PERKINS CAUFIELD & BYERS, 2750 SAND HILL ROAD, MENLO PARK CA 94025
Julie Washington	director	C/O JAMBA, INC., 6475 CHRISTIE AVENUE, NO. 150, EMERYVILLE CA 94608